Stock Analysis
Eli Lilly and Company (LLY) Stock Analysis
Eli Lilly and Company (LLY) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Eli Lilly and Company (LLY) currently has an AIQ Score of 43/100, indicating a neutral setup. Quality is the strongest factor at 76/100. Momentum is the weakest current factor at 23/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
LLY at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $1,165.59 |
| AIQ Score | 43/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Sell |
| Market Cap | $1.14T |
| P/E Ratio | 38.57 |
| Forward P/E | — |
| EPS | $7.95 |
| Revenue TTM | $22.97B |
| Dividend Yield | 6.46% |
| Beta | 0.51 |
| Volume | 862.85K |
| 52-week range | $712.05-$1,292.65 |
| RSI 14 | 39.58 |
| 50-Day SMA | $1,189.16 |
| 200-Day SMA | $1,061.33 |
| Analyst Price Target | $1,331.12 |
| Next Earnings | Oct 29, 2026 |
Create a free account to keep researching stocks
You have viewed 2 stock pages in the last 24 hours. Create a free account to keep researching current evidence.
LLY
OverviewLLY Stock Analysis Summary
Eli Lilly and Company (LLY) currently has an AIQ Score of 43/100/100, indicating a neutral setup. Quality is the strongest factor at 76/100/100. Momentum is the weakest current factor at 23/100/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, LLY has AIQ Score of 43/100 with Quality base of 76/100 and fading Momentum at 23/100. Wait for component alignment before adding exposure.
Quality (76/100) leads while Momentum (23/100) lags. This cross-factor spread creates entry timing uncertainty.
Healthcare · 0.48% stock move · LLY classified in Drug Manufacturers - General.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is LLY Bullish or Bearish Right Now?
LLY currently has a neutral overall setup. Quality is the strongest factor at 76/100, while Momentum is weakest at 23/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Quality is supportive at 76/100.
- - Analyst target implies +14.20% upside from the latest quote.
- - Value is the current constraint at 25/100.
- - Momentum is weak at 23/100.
- - Technical consensus has more sell votes than buy votes (28 vs 14).
Current Consensus
LLY's Technical Analysis Consensus is currently Sell, with 14 buy, 3 neutral, and 28 sell votes. LLY's 14-day RSI is 39.58, which places the stock in a weaker momentum range. LLY's beta is 0.51, indicating lower market sensitivity than the broad market.
What Changed in LLY?
Recent score-change history is not available in the current snapshot. The page still shows the latest market-close evidence and timestamps.
What Would Change the LLY Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
LLY Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
LLY Fundamentals
LLY valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
LLY Technical Analysis
LLY technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
LLY Stock Catalysts
Track LLY earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
LLY Dividend Analysis
LLY dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
LLY Financial Data
LLY revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
LLY Risk Analysis
LLY volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
LLY Stock News
LLY stock news, market tone, recent headlines, and catalyst context.
Popular LLY Comparisons
How LLY scores against the names it is most often compared with.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts8 recent quarterly periods are available for review.
Checked Sep 2, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Value and quality should explain the score, not sit behind it.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for LLY
Scenario Analysis
AIQ Scenario Builder
Eli Lilly and Company (LLY) Stock Analysis
Eli Lilly and Company has an AIQ Score of 43/100 in a Neutral regime. Quality is strongest at 76/100.
The main conflict is that quality leads at 76/100 while momentum lags at 23/100. Review the supporting factors together before drawing a conclusion from any single score.
Beta is 0.51, below market sensitivity. Current price is $1,165.59 and RSI (14) is 39.6.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | LLY is in a Neutral AIQ regime with score 43/100. |
| Signal Conflict | The primary conflict is that quality leads at 76/100 while momentum lags at 23/100. |
| Factor Evidence | Momentum 23/100 · Value 25/100 · Quality 76/100 · Risk 45/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
| Checklist | Status | Evidence |
|---|---|---|
| Factor strength | Pass | Quality is the strongest factor at 76/100. |
| Timing | Fail | Momentum is 23/100 and RSI (14) is 39.6. |
| Regime fit | Wait | LLY is in a Neutral regime at 43/100. |
| Risk control | Wait | Risk factor is 45/100 with beta 0.51 and annual volatility 35.89%. |
| Conflict | Wait | Current conflict: quality leads at 76/100 while momentum lags at 23/100. |
| AIQ Score | 43/100/100 |
| Price | $1,165.59 |
| Beta | 0.51 |
| RSI (14) | 39.6 |
Compare with Similar Stocks
Portfolio Implication
Related Links
Related Links
LLY Stock FAQ
What is LLY stock price today?
Eli Lilly and Company's current stock price is $1,165.59. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is LLY bullish or bearish right now?
LLY's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is LLY's market cap?
LLY's market cap is $1.14T based on the latest completed market-close snapshot from Sep 2, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is LLY's current P/E ratio?
LLY's current P/E ratio is 38.57 based on the latest completed market-close snapshot from Sep 2, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is LLY's RSI?
LLY's 14-day RSI is 39.58 based on the latest completed market-close snapshot from Sep 2, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is LLY above its 50-day and 200-day moving averages?
LLY is -1.98% from its 50-day SMA and 9.82% from its 200-day SMA based on the latest completed market-close snapshot from Sep 2, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is LLY's next earnings date?
LLY's next earnings date is currently listed as Oct 29, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does LLY pay a dividend?
LLY's dividend yield is 6.46% based on the latest completed market-close snapshot from Sep 2, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.